YBR144C Antibody

What is YBR144C and why is it studied with antibodies?

YBR144C is a putative protein of unknown function in Saccharomyces cerevisiae (baker's yeast). While conserved across S. cerevisiae strains, it is not an essential gene, making it an interesting target for functional characterization. The gene is located on chromosome II at positions 533235-533549, encoding a relatively small protein of 105 amino acids with a DNA length of 313 base pairs .

Antibodies against YBR144C serve as valuable tools for studying this protein's expression, localization, interactions, and potential functions. Since the protein's role remains uncharacterized despite its conservation, antibody-based approaches provide researchers with methods to investigate its biological significance without relying on prior functional knowledge.

How are antibodies generated against yeast proteins like YBR144C?

Generating antibodies against yeast proteins typically follows one of several established approaches:

• Recombinant protein expression: The YBR144C gene can be cloned and expressed in a bacterial system (commonly E. coli), purified using chromatography techniques, and used as an immunogen for antibody production in rabbits or other host animals.

• Synthetic peptide approach: Short, unique peptide sequences from YBR144C can be synthesized and conjugated to carrier proteins before immunization. This is particularly useful when working with a small protein like YBR144C (105 aa).

• Yeast surface display: Similar to the approach described for human antibodies, the YBR144C protein can be displayed on yeast cell surfaces for isolation and engineering of antibodies with desired properties .

When generating antibodies against yeast proteins, researchers must consider factors such as protein folding, post-translational modifications, and choosing sequences that maximize specificity while avoiding cross-reactivity with other yeast proteins.

How can researchers validate the specificity of YBR144C antibodies?

Validation of YBR144C antibodies should follow a multi-method approach:

• Western blot comparison: Compare wild-type yeast strains with YBR144C knockout strains . A specific antibody should show a band at the expected molecular weight (~12 kDa for YBR144C) in wild-type samples that is absent in knockout samples.

• Immunoprecipitation followed by mass spectrometry: Perform IP with the YBR144C antibody and analyze pulled-down proteins by mass spectrometry to confirm target identity.

• Immunofluorescence microscopy: Compare staining patterns between wild-type and knockout strains.

• Epitope mapping: Determine which regions of YBR144C are recognized by the antibody to predict potential cross-reactivity.

• Pre-absorption controls: Pre-incubate the antibody with purified YBR144C protein to demonstrate that this eliminates specific signal.

What are the optimal methods for using YBR144C antibodies in yeast cellular localization studies?

When studying YBR144C cellular localization, researchers should consider:

Immunofluorescence protocol optimization:

• Fixation method selection: Compare formaldehyde (preserves structure) versus methanol (better for some epitopes) fixation.

• Cell wall digestion: Optimize zymolyase or lyticase treatment to ensure antibody accessibility while maintaining cellular architecture.

• Permeabilization conditions: Test different detergents (e.g., Triton X-100, saponin) and concentrations.

• Blocking solutions: Use 3-5% BSA with normal serum from the secondary antibody species.

Controls and validation approaches:

• Co-localization studies: Use established markers for various cellular compartments (nucleus, ER, Golgi, mitochondria, vacuole) to determine YBR144C distribution.

• YBR144C-GFP fusion proteins: Compare antibody staining with GFP fluorescence in strains expressing tagged protein.

• Temperature-sensitive mutants: Utilize the established temperature-sensitive mutation methodology to generate conditional YBR144C mutants and observe localization changes.

Researchers should also consider that the small size of YBR144C (105 aa) might impact its detection sensitivity and may require signal amplification methods.

How can researchers use YBR144C antibodies to identify protein interaction partners?

Several methodologies can be employed to identify YBR144C interaction partners:

Co-immunoprecipitation approaches:

• Standard Co-IP: Use YBR144C antibodies conjugated to agarose or magnetic beads to pull down the protein and its interactors from yeast lysate.

• Cross-linking IP: Apply reversible cross-linkers to stabilize transient interactions before immunoprecipitation.

• Proximity-dependent labeling: Fuse YBR144C to enzymes like BioID or APEX2 to biotinylate proximal proteins.

Analysis methods for interactome determination:

• Mass spectrometry: Analyze co-immunoprecipitated proteins using LC-MS/MS.

• Western blot validation: Confirm specific interactions using antibodies against predicted partners.

• Yeast two-hybrid screening: Complement antibody-based approaches with Y2H to detect binary interactions.

When analyzing potential interactors, researchers should:

• Compare results with negative controls (IgG, unrelated antibody)

• Perform reverse Co-IPs with antibodies against identified partners

• Validate interactions through functional assays

• Consider bait expression levels that might affect interaction detection

What techniques can be applied for investigating YBR144C post-translational modifications using antibodies?

Since YBR144C is a protein of unknown function, identifying its post-translational modifications (PTMs) may provide crucial functional insights:

PTM-specific detection approaches:

• Modification-specific antibodies: For common PTMs like phosphorylation, acetylation, or ubiquitination.

• IP-mass spectrometry workflow:

  • Immunoprecipitate YBR144C using validated antibodies

  • Perform proteolytic digestion of purified protein

  • Analyze by high-resolution MS with PTM search parameters

  • Validate findings with site-specific antibodies or mutagenesis

Experimental verification strategies:

• Phosphorylation analysis:

  • Compare YBR144C phosphorylation under different growth conditions

  • Use phosphatase treatment to confirm phosphorylation-specific bands

  • Generate phospho-site mutants and observe functional consequences

• Ubiquitination/SUMOylation detection:

  • Immunoprecipitate YBR144C and probe with anti-ubiquitin/SUMO antibodies

  • Express tagged ubiquitin/SUMO constructs to enhance detection

• Site-directed mutagenesis validation:

  • Mutate predicted modification sites

  • Assess impact on protein stability, localization, and function

How should researchers address potential cross-reactivity when using YBR144C antibodies?

Cross-reactivity is a common challenge with antibodies, especially for poorly characterized proteins like YBR144C:

Cross-reactivity assessment methods:

• Western blot testing against multiple yeast strains: Include wild-type, YBR144C knockout, and strains with varying expression levels.

• Epitope mapping: Identify which protein regions are recognized by the antibody to predict potential cross-reactivity.

• Database cross-checking: Search for proteins with similar sequences to the YBR144C epitope(s).

Mitigation strategies:

• Affinity purification: Purify polyclonal antibodies using immobilized antigen columns.

• Pre-absorption: Incubate antibodies with lysates from YBR144C knockout strains to remove non-specific antibodies.

• Blocking optimization: Test different blocking reagents (BSA, milk, commercial blockers) to reduce background.

• Secondary antibody controls: Include controls without primary antibody to detect non-specific secondary antibody binding.

Data interpretation considerations:

• Band pattern analysis: Document all observed bands and their molecular weights.

• Multiple antibody verification: When possible, use antibodies targeting different epitopes of YBR144C.

• Independent technique confirmation: Validate findings with non-antibody methods (e.g., MS, RNA expression).

What are the most effective protocols for chromatin immunoprecipitation (ChIP) using YBR144C antibodies?

Although YBR144C is not characterized as a DNA-binding protein, investigating its potential association with chromatin may reveal unexpected functions:

ChIP optimization for YBR144C:

• Crosslinking optimization:

  • Test formaldehyde concentrations (1-3%)

  • Optimize crosslinking times (10-30 minutes)

  • Consider dual crosslinkers for protein-protein preservation

• Sonication parameters:

  • Adjust sonication conditions to achieve 200-500 bp fragments

  • Verify fragmentation by agarose gel electrophoresis

  • Consider enzymatic fragmentation alternatives

• Immunoprecipitation conditions:

  • Compare different antibody concentrations

  • Test various bead types (protein A/G, magnetic vs. agarose)

  • Optimize washing stringency to reduce background

Controls and validation approaches:

• Input samples: Use 5-10% of pre-IP chromatin as reference

• IgG control: Perform parallel IP with non-specific IgG

• Knockout control: Include YBR144C knockout strain

• Positive control regions: Include primers for known DNA regions if functionality is suggested

• Negative control regions: Include primers for regions unlikely to be associated with YBR144C

Analysis methods:

• qPCR: For targeted analysis of specific genomic regions

• ChIP-seq: For genome-wide analysis of binding patterns

• ChIP-exo/ChIP-nexus: For high-resolution binding site mapping

How does the methodology for YBR144C antibody research compare with approaches used for other yeast proteins?

When studying an uncharacterized protein like YBR144C, researchers can benefit from comparing methodologies used for both characterized and uncharacterized yeast proteins:

Methodological comparison table:

Strategy adaptation recommendations:

• Leverage methods from well-characterized yeast proteins while implementing more stringent controls

• Consider epitope tagging (HA, Myc, FLAG) as complementary to antibody-based detection

• Implement systematic genetic screens alongside antibody studies to correlate physical interactions with genetic relationships

• Utilize the established temperature-sensitive mutation methodology to generate conditional YBR144C mutants if standard knockout approaches provide limited insights

How can researchers integrate YBR144C antibody data with other -omics approaches for comprehensive functional characterization?

A multi-omics integration strategy can provide complementary insights into YBR144C function:

Data integration framework:

• Antibody-based proteomics:

  • IP-MS to identify interaction partners

  • PTM mapping to understand regulation

  • Localization studies to determine cellular context

• Transcriptomics integration:

  • RNA-seq of YBR144C knockout versus wild-type

  • Analysis of gene expression changes upon YBR144C overexpression

  • Correlation of YBR144C expression with gene clusters across conditions

• Metabolomics connections:

  • Metabolite profiling in YBR144C mutants

  • Identification of altered metabolic pathways

  • Correlation with protein interaction data

• Genetic interaction mapping:

  • Synthetic genetic array analysis with YBR144C knockout

  • Chemical-genetic profiling using barcoded yeast strains

  • Comparison with genetic interaction profiles of known proteins

Computational analysis approaches:

• Network integration: Combine protein-protein, genetic, and metabolic networks

• Functional enrichment: Analyze GO terms, KEGG pathways, and protein domains of interacting partners

• Evolutionary analysis: Compare YBR144C conservation and co-evolution patterns with interacting proteins

• Structural prediction: Use AlphaFold or similar tools to predict structure and functional sites

By systematically integrating antibody-derived data with other -omics approaches, researchers can develop testable hypotheses about YBR144C function despite its current uncharacterized status.